Heikki Kuusanmäki
5PUBLICATIONS
52CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.Ida Vänttinen, Joseph Saad, Tanja Ruokoranta
|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia.Yingjia Chen, Liye He, Aleksandr Ianevski
|Oct 02, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta
|Apr 01, 2024
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab-Auristatin Conjugate with a Wide Therapeutic Window.Tero Satomaa, Henna Pynnönen, Olli Aitio
|Dec 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela
Pageof 1
Frequent Collaborators
5 joint publications
Caroline A Heckman
5 joint publications
Mika Kontro
4 joint publications
Ida Vänttinen
3 joint publications
Tanja Ruokoranta
3 joint publications
Joseph Saad
3 joint publications
Kimmo Porkka
2 joint publications
Markus Vähä-Koskela
2 joint publications
Juho Miettinen
1 joint publications
Olli Dufva
1 joint publications
Petra Nygren
